Genesus Inc. is a leading swine genetics company based in Canada, recognized as the world's largest independent producer of high-health registered purebred swine. The company owns over 80% of all registered purebred breeding stock in Canada, focusing on Non-GMO swine genetic improvement to enhance customer profitability through sow reproduction, feed intake and growth performance, natural disease resistance, and carcass and meat quality. In June 2024, Genesus underwent a strategic restructuring, leading to the formation of Genesus Genetic Technologies, aiming to continue delivering superior genetic advancements globally.